Latest Type 1 hypersensitivity Stories
DUBLIN, March 20, 2015 /PRNewswire/ -- Dignity Sciences (DS) is today presenting a late-breaking news abstract at the annual meeting of the American Association of Dermatology
Epicutaneous, or “skin patch”, peanut immunotherapy may become the first FDA-approved form of therapy for peanut allergy. Colorado Springs (PRWEB) March
Data from an assessment of more than 6,000 schools provide information about anaphylaxis triggers, response and education in the school setting PITTSBURGH, Feb.
- 90% of subjects had reduction of free IgE to below the limit of detection by the end of XmAb7195 infusion, including at lowest dose evaluated of 0.3 mg/kg - MONROVIA, Calif.,
Allegheny Health Network Study Raises Concerns About OTC Availability of Common Treatment for Allergy Symptoms PITTSBURGH, Pa (PRWEB) January 26, 2015
JDP Therapeutics Inc., a privately held specialty pharmaceutical company, is pleased to announce that the Company has successfully completed the initial Phase 3 clinical trial (ETTAU-02) on its
MISSISSAUGA, ON, Dec. 22, 2014 /PRNewswire/ - Nuvo Research Inc.
DALLAS, December 17, 2014 /PRNewswire/ -- RnRMarketResearch.com adds "Chronic Urticaria Or Hives - Pipeline Review, H2 2014" therapeutic market research report of 67 pages
TARRYTOWN, N.Y. and PARIS, Nov. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.
Exposure to peanut proteins in household dust may be a trigger of peanut allergy, according to a study published today in the Journal of Allergy and Clinical Immunology. New
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.